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Introduction 
Rare pancreatic carcinomas (PC) account for roughly 15% of all pancreatic cancers and 
approximately 8,300 new cases within the US annually.  Little research compares initial stage at 
diagnosis among rare vs. common pancreatic tumors.  The aim of this study was to examine 
associations between tumor histology and initial stage at diagnosis among cases of rare 
pancreatic cancers. 
 
Methods 
Retrospective cohort study, using the NCI’s Surveillance, Epidemiology, and End 
Results (SEER) 1990-2015 database. We included patients diagnosed with pancreatic cancer 
aged 18+. Histology was classified into four categories (ductal, carcinoid, mucinous 
adenocarcinoma, and undetermined) and stage was dichotomized (locoregional versus distant). 
Multivariate logistic regression was used to describe the association between tumor histology 
with initial stage at diagnosis, controlling for patient and tumor characteristics. 
 
Results 
90,764 PC patients were analyzed: 9.60%(ductal carcinomas), 4.47%(carcinoid), 
3.78%(mucinous), and 15.81%(undetermined); 54.74% of cases were distantly metastasized at 
diagnosis. In multivariate analysis, PC patients with mucinous histology had greater odds of 
presenting with late-stage disease compared to those with adenocarcinoma 
(OR=141%,CI=131,152%; carcinoid and undetermined neoplasm findings were not significant 
(OR=99.1%CI=92.3,106.5% and OR=101.3%Cl=97.3%,105.4% respectively). Other factors 
associated with distant PC included age 40-59, male sex, and African American background. 
 
Discussion 
We observed that mucinous histology has a greater risk of late-stage diagnosis while 
carcinoid and undetermined neoplasms had a similar risk of late-stage diagnosis vs. 
adenocarcinoma. 
 
 
 


